ALX Oncology Holdings, Inc. is a company in the U.S. stock market and it is a holding in 40 U.S.-traded ETFs. ALXO has around 2.2M shares in the U.S. ETF market. The largest ETF holder of ALXO is the SPDR S&P Biotech ETF (XBI), with approximately 781.20K shares. Investors may also find of interest that the ETF with the largest allocation to ALXO stock is Loncar Cancer Immunotherapy ETF (CNCR), with a portfolio weight of 3.80%. On average, U.S. ETFs allocate 0.23% of ALXO to their portfolios.
Additionally, ALXO is a favorite stock for Vanilla and Equal ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ALXO as a holding is the ProShares UltraPro Russell2000 (URTY), with a return of 167.77%.